The process may be induced by activation or dysregulation of oncogenic pathways (e.g., TGF-β, EGF, NF-κB and Wnt), hypoxia-induced expression of HIF-1α, or factors produced by the tumor microenvironment [54]. Here, TGFB1 is linked to neoplasm.